WIN 55,212-2 MESYLATE
- CAS NO.:1308285-21-3
- Empirical Formula: C23H34N6O7S2
- Molecular Weight: 570.68
- Update Date: 2024-11-19 20:33:22
What is WIN 55,212-2 MESYLATE?
Description
Sildenafil is the first phosphodiesterase 5 (PDE5) inhibitor developed by Pfizer in the United States for the treatment of erectile dysfunction in men. Its commercial name is Viagra. Sildenafil was first entered into clinical research as a 5-phosphodiesterase inhibitor for the treatment of cardiovascular disease, but clinical studies have shown that the effect of sildenafil on cardiovascular disease did not meet the expectations of researchers , and later researchers found that this drug improved the patient's sex life.
Biological Activity
sildenafil mesylate is an inhibitor of cyclic guanosine monophosphate (cgmp)-specific phosphodiesterase type 5 (pde5).pde5 is the predominant phosphodiesterase in the corpus cavernosum. the catalytic site of pde5 degrades cgmp, and pde5 inhibitors can potentiate endogenous increases in cgmp.
Pharmacology
Sildenafil mesylate is the mesylate form of sildenafil and has the same pharmacological effects as sildenafil. Sildenafil is a selective 5-phosphodiesterase inhibitor that enhances nitric oxide-dependent pulmonary vasodilation mediated by cyclic guanosine monophosphate by inhibiting the breakdown of cyclic guanosine monophosphate. In addition to the direct expansion of pulmonary blood vessels, it can also prevent or reverse vascular remodeling.
in vitro
sildenafil mesylate had been identified as a potent pde5 reversible and selective inhibitor. sildenafil enhanced sodium nitroprusside- or transmural electrical stimulation-induced relaxation of precontracted corpus cavernosum muscle strips in organ baths. sildenafil also increased intracellular cgmp concentrations in cultured smooth muscle cells treated with sodium nitroprusside [1].
in vivo
in anesthetized dogs, sildenafil could enhance the erectile function following pelvic nerve stimulation as measured by increased intracavernosal pressure [1].
References
[1] nehra a,colreavy f,khandheria bk,chandrasekaran k. sildenafil citrate, a selective phosphodiesterase type 5 inhibitor: urologic and cardiovascular implications. world j urol.2001 feb;19(1):40-5.
[2] moore ra,edwards je,mcquay hj. sildenafil (viagra) for male erectile dysfunction: a meta-analysis of
Properties of WIN 55,212-2 MESYLATE
storage temp. | under inert gas (nitrogen or Argon) at 2-8°C |
solubility | ≥57.1 mg/mL in DMSO; insoluble in EtOH; ≥25.95 mg/mL in H2O |
form | solid |
Safety information for WIN 55,212-2 MESYLATE
Computed Descriptors for WIN 55,212-2 MESYLATE
New Products
(S)-3-Aminobutanenitrile hydrochloride 4-Methylphenylacetic acid N-Boc-D-alaninol N-BOC-D/L-ALANINOL Tert-butyl bis(2-chloroethyl)carbamate 3-Morpholino-1-(4-nitrophenyl)-5,6-dihydropyridin- 2(1H)-one Furan-2,5-Dicarboxylic Acid Tropic acid 1-Bromo-3,5-Di-Tert-Butylbenzene S-2-CHLORO PROPIONIC ACID ETHYL ISOCYANOACETATE 2-Bromo-1,3-Bis(Dimethylamino)Trimethinium Hexafluorophosphate 4-IODO BENZOIC ACID 3-NITRO-2-METHYL ANILINE 1-(2,4-DICHLOROPHENYL) ETHANAMINE (2-Hydroxyphenyl)acetonitrile 4-Bromopyrazole 2-(Cyanocyclohexyl)acetic acid 4-methoxy-3,5-dinitropyridine 1-(4-(aminomethyl)benzyl)urea hydrochloride 2-aminopropyl benzoate hydrochloride diethyl 2-(2-((tertbutoxycarbonyl)amino) ethyl)malonate tert-butyl 4- (ureidomethyl)benzylcarbamate Ethyl-2-chloro((4-methoxyphenyl)hydrazono)acetateRelated products of tetrahydrofuran
You may like
-
2033-24-1 98%View Details
2033-24-1 -
42831-50-5 5-METHYLISOXAZOLE-4-CARBOXYLIC ACID 98%View Details
42831-50-5 -
1975-50-4 98%View Details
1975-50-4 -
2-HYDROXY BENZYL ALCOHOL 98%View Details
90-01-7 -
2-Chloro-1,3-Bis(Dimethylamino)Trimethinium Hexafluorophosphate 221615-75-4 98%View Details
221615-75-4 -
61397-56-6 CIS BROMO BENZOATE 98%View Details
61397-56-6 -
14714-50-2 (2-Hydroxyphenyl)acetonitrile 98+View Details
14714-50-2 -
118753-70-1 98+View Details
118753-70-1